For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.
BASEL (dpa-AFX) - Novartis (NVS) said new Piqray data showed benefit across a broad range of patient and disease characteristics in analyses from all three cohorts of BYLieve, an ongoing phase
New data underscore efficacy of Piqray, even in those patients with a short treatment duration on prior CDK4/6i or with ESR1 mutations, biomarkers of endocrine resistance1-5 Recent guideline updates
Transcripts for MSNBC The Beat With Ari Melber 20200623 22:45:15 archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.